[Effectiveness of local application of cidipol in the treatment and prevention of infectious-inflammatory diseases of the urogenital organs in women].
The efficacy of cidipol used locally in the treatment of infectious inflammatory diseases of the urogenital tracts and in the prophylaxis of urinary tract infection (UTI) in transurethral instrumental interventions (TII) was studied microbiologically and clinically in 42 females at the age of 18 to 51 years. In the treatment of 23 female patients the drug showed good clinical effects. The eradication of the primary pathogen was stated in 16 patients. When used prophylactically before TII in 19 patients no infectious inflammatory complications were observed in any of the females. The data are evident of the possible use of cidipol in the treatment (local application) of infectious inflammatory diseases of the urogenital tracts in females and in the prophylaxis of UTI in TII.